Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 3/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | THRA | P10827 | 1/20 | 0.54 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | RARB | P10826 | 1/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.47 |
| ▸ | PLK1 | P53350 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL248390 | 0.95 | THRB (0.63) | THRBALDH1A1HPGDHSD17B10THRA | |
| SCHEMBL5165582 | 0.94 | THRB (0.62) | THRBALDH1A1HSD17B10THRARARB | |
| SCHEMBL247206 | 0.94 | THRB (0.62) | THRBALDH1A1HSD17B10THRARARB | |
| SCHEMBL5166821 | 0.94 | THRB (0.62) | THRBALDH1A1HSD17B10THRARARB | |
| SCHEMBL249214 | 0.94 | THRB (0.62) | THRBALDH1A1HSD17B10THRARARB | |
| SCHEMBL233924 | 0.93 | THRB (0.63) | THRBALDH1A1HPGDHSD17B10THRA | |
| SCHEMBL17473054 | 0.92 | RARB (0.58) | THRBALDH1A1HPGDHSD17B10THRA | |
| SCHEMBL10706439 | 0.90 | THRB (0.69) | THRBALDH1A1HPGDHSD17B10THRA | |
| SCHEMBL10708974 | 0.90 | THRB (0.60) | THRBALDH1A1HPGDHSD17B10THRA | |
| SCHEMBL360649 | 0.90 | THRB (0.60) | THRBALDH1A1THRAFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 279 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-14 | — | — | US | disclosed |
| EP-3055342-B1 | PROCESS FOR PREPARING POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES USING A SALT OF A WEAK ACID | COVESTRO DEUTSCHLAND AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12365775-B2 | Process for partial colouring of plastic parts using solid colourants in colour- carrier layers | COVESTRO DEUTSCHLAND AG (DE) | 2025-07-22 | — | — | US | disclosed |
| US-20250205963-A1 | METHOD FOR PRODUCING A PLASTIC MOLDING | tooz technologies GmbH (DE) | 2025-06-26 | — | — | US | disclosed |
| EP-4549163-A2 | IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS | Covestro Deutschland AG (DE) | 2025-05-07 | — | — | EP | disclosed |
| EP-2593288-B2 | APPARATUS AND PROCESS FOR PRODUCING PRODUCTS FROM PIGMENT-CONTAINING POLYMER MIXTURES | COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) | 2025-04-16 | — | — | EP | disclosed |
| US-20250091332-A1 | FILM STRUCTURE SUITABLE FOR RAPID LAMINATION | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-20 | — | — | US | disclosed |
| EP-3055344-B1 | POLYSILOXANE-POLYCARBONATE BLOCK COCONDENSATES | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-12 | — | — | EP | disclosed |
| EP-3840958-B1 | IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS | COVESTRO DEUTSCHLAND AG (DE) | 2025-02-19 | — | — | EP | disclosed |
| EP-4493388-A1 | METHOD FOR PRODUCING A PLASTIC MOLDING | tooz technologies GmbH (DE) | 2025-01-22 | — | — | EP | disclosed |
| US-20040127677-A1 | Polycarbonates, polyester carbonates and polyesters having lateral, cycloalkyl-substituted phenols | BAYER AKTIENGESELLSCHAFT (DE) | 2004-07-01 | — | — | US | disclosed |
| US-6753405-B2 | MORE THAN 35 MOLE % OF UNITS DERIVED FROM DIHYDROXYDIPHENYLENE AND THE REST FROM AN ALKYLIDENE OR CYCLOALKYLIDENE BISPHENOL; PREPARED BY MELT TRANSESTERIFICATION; USED TO PREPARE TRANSPARENT MOLDINGS | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-22 | — | — | US | disclosed |
| US-20040103717-A1 | Process for the production of polycarbonate which is damaged to a particularly small extent by oxygen | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-03 | — | — | US | disclosed |
| EP-1412411-A2 | PROCESS FOR PREPARING POLYCARBONATE AND APPARATUS FOR PREPARING POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2004-04-28 | — | — | EP | disclosed |
| US-6620902-B2 | Melting aromatic dihydroxy compound, a carbonic acid diester; mixing with endcapping agent under hermetic sealing | GENERAL ELECTRIC COMPANY | 2003-09-16 | — | — | US | disclosed |
| US-20030088051-A1 | Process for preparing polycarbonate and apparatus for preparing polycarbonate | GENERAL ELECTRIC COMPANY | 2003-05-08 | — | — | US | disclosed |
| US-20030055201-A1 | Process for optimising the production of polycarbonate by melt transesterification | BAYER AKTIENGESELLSCHAFT (DE) | 2003-03-20 | — | — | US | disclosed |
| US-20030027971-A1 | Preparation of copolycarbonates | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-06 | — | — | US | disclosed |
| WO-2003008481-A2 | PROCESS FOR PREPARING POLYCARBONATE AND APPARATUS FOR PREPARING POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 2003-01-30 | — | — | WO | disclosed |
| US-20020137874-A1 | Process for producing oligocarbonates | COVESTRO DEUTSCHLAND AG (DE) | 2002-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12600116-B2 | Special polymer layers for faster laminability of multilayer structures | ASH2L, SMC2, ELL | THRB 3930/4885ALDH1A1 4181/4885HPGD 4856/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.